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Abstract. 
 
Many receptors for endocytosis recycle into
and out of cells through early endosomes. We now ﬁnd
in dendritic cells that the DEC-205 multilectin receptor
targets late endosomes or lysosomes rich in major his-
tocompatibility complex class II (MHC II) products,
whereas the homologous macrophage mannose recep-
tor (MMR), as expected, is found in more peripheral
endosomes. To analyze this ﬁnding, the cytosolic tails of
DEC-205 and MMR were fused to the external domain
of the CD16 Fc
 
g
 
 receptor and studied in stable L cell
transfectants. The two cytosolic domains each mediated
rapid uptake of human immunoglobulin (Ig)G followed
by recycling of intact CD16 to the cell surface. How-
ever, the DEC-205 tail recycled the CD16 through
MHC II–positive late endosomal/lysosomal vacuoles
and also mediated a 100-fold increase in antigen pre-
sentation. The mechanism of late endosomal targeting,
which occurred in the absence of human IgG, involved
two functional regions: a membrane-proximal region
with a coated pit sequence for uptake, and a distal re-
gion with an EDE triad for the unusual deeper target-
ing. Therefore, the DEC-205 cytosolic domain mediates
a new pathway of receptor-mediated endocytosis that
entails efﬁcient recycling through late endosomes and a
greatly enhanced efﬁciency of antigen presentation to
CD4
 
1
 
 T cells.
Key words: dendritic cell • antigen presentation •
DEC-205 • MHC class II • endocytosis 
 
Introduction
 
Several cell surface receptors deliver ligands to the en-
docytic system for purposes of extensive intracellular di-
gestion within lysosomes. Many of these receptors func-
tion exclusively in endocytosis, such as the prototype
low-density lipoprotein receptor (LDLR)
 
1 
 
(Brown et al.,
1983) and asialoglycoprotein receptor (Ciechanover et al.,
1983). These localize to coated pits, dramatically increas-
ing uptake via coated vesicles. After ligand release in early
endosomes, the receptors recycle rapidly to the cell sur-
face. By avoiding proteolysis during this recycling, such re-
ceptors are ideal for nutrient delivery and scavenging, e.g.,
cholesterol, iron, and altered glycoproteins. Other recep-
tors, e.g., those for immune complexes (Amigorena et al.,
1992a) and certain growth factors (Wilde et al., 1999),
have signaling functions in addition to mediating adsorp-
tive uptake of their ligands. The receptors typically are
catabolized in lysosomes, rather than recycled, after up-
take of immune complexes and growth factors (Mellman
et al., 1983). This receptor downregulation can dampen
signal transduction. The ligands for both recycling and
nonrecycling families of endocytic receptors are digested
in lysosomes down to the level of amino acids. Digestion
must be complete, since amino acids and monosaccharides
are then able to diffuse out of the lysosomal system. In-
complete digestion, as occurs with lysosomal enzyme defi-
ciency, leads to vacuolar swelling (Cohn and Ehrenreich,
1969; Ehrenreich and Cohn, 1969).
Adsorptive endocytosis receptors, like the macrophage
mannose receptor (MMR), FcR, and B cell antigen recep-
tor (BCR), are used in the immune system to facilitate an-
tigen capture and presentation of peptides to T cells (Bon-
nerot et al., 1992; Sallusto et al., 1995; Engering et al., 1997).
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Abbreviations used in this paper:
 
 aggHuIgG, aggregated human IgG;
BCR, B cell antigen receptor; CHX, cycloheximide; DC, dendritic cell;
ICAM, intracellular adhesion molecule; LAMP-1, lysosome-associated
membrane protein 1; LDLR, low-density lipoprotein receptor; MMR,
macrophage mannose receptor; MHC II, major histocompatibility com-
plex class II; MIIC, MHC II compartment; PLA2R, phospholipase A2 re-
ceptor; TfR, transferrin receptor. 
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Previously we have identified an endocytic receptor,
termed DEC-205, expressed by dendritic cells (DCs). This
205-kD protein contains 10 external, contiguous, C-type
lectin domains and by sequence analysis, is a homologue of
the MMR. In fact, both the MMR and DEC-205 mediate
adsorptive uptake, and both have cytosolic domains with
requisite coated pit localization sequences (Stahl et al.,
1980; Jiang et al., 1995). Therefore, we expected that both
MMR and DEC-205 would recycle through early endoso-
mal compartments and present bound antigens compara-
bly. However, we will show that DEC-205 unexpectedly
targets to late endosomes or lysosomes in developing DCs,
and that DEC-205 is far superior to the MMR in present-
ing bound rabbit antireceptor antibodies to T cells, a classi-
cal assay for measuring the presenting function of endocy-
tosis receptors (Chesnut and Grey, 1981).
To dissect the role of the cytosolic domain in these find-
ings, we studied a totally heterologous system: L cells sta-
bly transfected with a fusion receptor formed between the
external domains of human CD16 and different cytosolic
tails. We find that the DEC-205 cytosolic domain has a dis-
tinct distal region with an acidic EDE triad. The distal re-
gion and its acidic sequence are required for recycling
beyond early endosomes through deeper major histocom-
patibility complex class II–positive (MHC II
 
1
 
), late endo-
somes and lysosomes. Such distal targeting is unique for
adsorptive endocytosis receptors that have been analyzed
to date, and proves to be necessary for presentation of an-
tigenic peptides at low doses of ligand. This new pathway
for receptor-mediated uptake is therefore a hybrid of the
two known endocytic pathways discussed above, targeting
deeper digestive compartments but recycling efficiently to
produce biologically active peptides.
 
Materials and Methods
 
Cells
 
The MHC II (I-E
 
k
 
)–expressing cell line DCEK.ICAM.Hi7 was main-
tained in RPMI with 7.5% Ig-depleted FCS (Atlanta Biologicals), 10 IU/
ml penicillin/streptomycin, 200 
 
m
 
M/ml glutamine (GIBCO BRL), and 50
 
m
 
M 2-mercaptoethanol (Sigma-Aldrich) (R7 medium). To maintain MHC
II and intracellular adhesion molecule (ICAM)-1 expression, every other
week the cells were kept in MXH medium (R7 containing 6 
 
m
 
g/ml myco-
phenolic acid, 250 
 
m
 
g/ml xanthine, 15 
 
m
 
g/ml hypoxanthine [all from
Sigma-Aldrich], and 800 
 
m
 
g/ml G418 [GIBCO BRL]). CD16 chimeric re-
ceptor transfectants were kept in MXH medium additionally supple-
mented with 5 
 
m
 
g/ml puromycin (Calbiochem). DCs were generated from
mouse bone marrow cultured in the presence of GM-CSF as described
previously (Inaba et al. 1992). Day 6 DCs are primarily at an immature,
antigen-capturing stage of development (Pierre et al., 1997).
 
Cloning and Transfection
 
The cDNAs coding for the intracellular domains of DEC-205 and MMR
were cloned separately from the extracellular expressed domains into a TA
vector (Invitrogen), and oligonucleotide directed mutagenesis using
QuikChange
 
®
 
 (Stratagene) was performed. STOP codons and a tyrosine to
alanine exchange were introduced into different parts of the DEC tail (see
Fig. 1 A). All mutations were verified by sequencing (DNA Technology
Center, The Rockefeller University). Using standard methods, the mutated
DEC tails were cloned into the BamH1-EcoR1 site of the pApuro vector
(gift of Dr. Kurosaki, American Cynamid Company, Lederle Laboratories,
Department of Cardiovascular Molecular Biology, Pearl River, NY) be-
hind the sequence coding for the extracellular domain of the human Fc
 
g
 
III
receptor (Kolanus et al., 1993). After verifying the correct insertion by se-
quencing, these constructs were transfected into the MHC II
 
1
 
 (I-E
 
k
 
) fibro-
 
blast cell line DCEK.ICAM.Hi7 by calcium phosphate precipitation (Strat-
agene). Thereafter, cells were split into 100-mm dishes and for selection,
puromycin (Calbiochem) was applied at a final concentration of 5 
 
m
 
g/ml.
Colonies growing under selection after 2–3 wk were picked and expanded.
Surface expression of CD16 was regularly monitored by FACS
 
®
 
, using
anti-CD16 antibody (clone 3G8).
 
Flow Cytometric Analysis of Surface Markers
 
Cells were harvested with trypsin (Boehringer), then incubated with cold
PBS/7% normal goat serum (vol/vol) followed by incubation for 45 min
on ice with the following hybridoma supernatants: anti–MHC II (14-4-4S;
American Type Culture Collection), anti–ICAM-1 (YN-1; American
Type Culture Collection), and anti-CD16 (3G8). B7 expression was as-
sayed with anti–B7-1 antibody (1G10; BD PharMingen). After washing
with cold PBS/1% FCS (vol/vol), FITC-labeled mouse anti–rat Ig or goat
anti–mouse Ig (Jackson ImmunoResearch Laboratories) secondary re-
agents at a final dilution of 1 
 
m
 
g/ml in PBS/1% FCS (vol/vol) were added.
After 45 min on ice, cells were washed and resuspended in PBS containing
1 
 
m
 
M propidium iodide (Sigma-Aldrich) to gate out dead cells during
analysis for fluorescence using a FACScan™ (Becton Dickinson).
 
Surface Binding and Internalization of Human IgG
 
Human IgG (HuIgG; Jackson ImmunoResearch Laboratories) was di-
luted to 1 mg/ml in PBS. Aggregates were formed by incubation at 65
 
8
 
C
for 30 min. Thereafter, aliquots were stored at 4
 
8
 
C until use, but no longer
than 1 wk. In some antigen-presenting assays, HuIgG was aggregated by
incubation with goat anti-HuIgG antibodies for 4 h at room temperature.
To assay surface binding of HuIgG, cells were harvested and washed with
cold PBS/1% FCS (vol/vol) and incubated for 45 min on ice with mono-
meric or aggregated HuIgG (aggHuIgG) at 0.1–100 
 
m
 
g/ml. After washes
with cold PBS/1% FCS (vol/vol), FITC-labeled goat anti–human IgG anti-
bodies (Jackson ImmunoResearch Laboratories) at a final concentration
of 1 
 
m
 
g/ml in PBS/1% FCS (vol/vol) were added. After 45 min on ice, cells
were washed, resuspended in PBS, and analyzed on a FACScan™. To
measure internalized HuIgG, the DCEK.ICAM.Hi7 cells were seeded
into 96-well plates (20,000 cells/well), cultured overnight, and transferred
on ice followed by addition of HuIgG at a final concentration of 50 
 
m
 
g/ml.
After 45 min, unbound HuIgG was removed by washing with medium,
and aliquots of cells were harvested and fixed with 4% paraformaldehyde
(PFA). The remaining cells were further incubated in R7 at 37
 
8
 
C after
which the cells were harvested, fixed, and stained with FITC-labeled goat
anti–human IgG antibodies as described above. To detect internalized
HuIgG, cells were permeabilized before adding FITC-labeled goat anti–
human antibodies, using a 10-min incubation with PBS/0.1% (vol/wt) sa-
ponin (Sigma-Aldrich). In time course experiments, the amount of inter-
nalized HuIgG was calculated by subtracting the mean fluorescence in
fixed cells (surface-bound HuIgG) from that recorded with fixed and per-
meabilized cells (internalized and surface-bound HuIgG).
 
Receptor Recycling
 
Cells were cultured for 2 h in 10 
 
m
 
g/ml cycloheximide (CHX; Calbio-
chem), sufficient to block protein biosynthesis as assessed by [
 
35
 
S]me-
thionine labeling (not shown). Surface CD16 then was saturated by incu-
bating the cells in presence of CXH with aggHuIgG (100 
 
m
 
g/ml) at 37
 
8
 
C
for 10 min, followed by chilling the cells for 1 h on ice. Thereafter, cells
were cultivated in R7 supplemented with CXH, and at different times, re-
cycled CD16 receptors were detected by incubation with 
 
125
 
I-HuIgG at 10
 
m
 
g/ml on ice. Bound HuIgG was measured by 
 
g
 
 counting (Wallac).
 
Confocal Immunofluorescence Microscopy of 
L Cells and DCs
 
L cells were seeded into LabTek tissue culture chambers (Nunc) and incu-
bated overnight. Cells were washed twice with warm RPMI medium, fixed
with 4% paraformaldehyde/PBS (wt/vol) for 20 min at room temperature,
and permeabilized by incubation with permeabilization buffer (RPMI con-
taining 10% normal goat serum [GIBCO BRL], 0.05% saponin [Sigma-
Aldrich], 10 mM glycine [Sigma-Aldrich]) for 15 min at room temperature.
Alternatively, DCs were grown from bone marrow precursors using GM-
CSF as described (Inaba et al., 1992). At day 6, when the cultures contain
numerous aggregates of immature DCs with abundant MHC II compart-
ments (MIICs) (Pierre et al., 1997), the cells were dislodged and applied to
alcian blue–coated, glass slides for fixation as above. After two washes in 
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permeabilization buffer, cells were incubated for 45 min at room tem-
perature with the following antibodies: anti–MHC II (M5/114; American
Type Culture Collection), anti–lysosome-associated membrane protein 1
(LAMP-1) (clone ID-4B; gift of Dr. Ira Mellman, Yale University School of
Medicine, New Haven, CT), anti-transferrin receptor (TfR) (C2F2; Ameri-
can Type Culture Collection), anti-CD16 (clone 3G8), and either mono-
clonal or polyclonal antibody to DEC-205 (Swiggard et al., 1995) and MMR
(prepared in rabbits by immunization with cloned MMR external domains).
In double labeling experiments, FITC-conjugated MHC II and LAMP-1
antibodies (BD PharMingen) were used. For unconjugated antibodies, we
stained cells for 45 min in permeabilization buffer with appropriate FITC-
or Texas red–labeled secondary reagents, absorbed against mouse or rat
proteins and applied at a final concentration of 1 
 
m
 
g/ml. For detection of en-
docytosed HuIgG, FITC-labeled goat anti-HuIgG was applied at 1 
 
m
 
g/ml in
permeabilization buffer. Slides were mounted in aquamount (Polysciences)
and examined by confocal laser scan microscopy (ZEISS). ZEISS software
was used to take and to overlay pictures. Composite figures were made us-
ing Photoshop
 
®
 
 (Adobe Systems).
 
Antigen Presentation to T Cells
 
To obtain HuIgG- or RbIgG-specific T cells, 6–8-wk-old B10.BR mice
(The Jackson Laboratory) were primed to HuIgG or RbIgG by subcuta-
neous injection of 50 
 
m
 
g HuIgG or RbIgG emulsified in complete Freund’s
adjuvant (Difco). In some experiments, mice were primed to RbIgG using
anti–DEC-205 Rb antiserum or anti-MMR Rb antiserum. 8 d later, drain-
ing lymph nodes were removed and single cell suspensions were prepared
by teasing with forceps and forcing the nodes through a nylon mesh. T
cells were purified by passage over nylon wool columns and incubating the
eluted cells with antibodies directed against MHC II (M5/114; American
Type Culture Collection) and CD45 (B220; American Type Culture Col-
lection) on ice for 30 min. In some experiments, anti-CD8 antibodies (TIB
211; American Type Culture Collection) were added to obtain purified
CD4
 
1
 
 T cells. Cells were washed and incubated with goat anti–rat Dyna-
beads (Dynal) at a ratio of 4 beads to 1 target cell for an additional 30 min
at 4
 
8
 
C to remove non-T cells. For antigen presentation assays with
DCEK.ICAM.Hi7 cells, transfected and untransfected DCEK.ICAM.Hi7
cells were irradiated with 5,000 rads and seeded into 96-well plates (15,000
cells/well). HuIgG was added to the cells in graded doses. After overnight
culture, unbound HuIgG was removed by washing the plates with warm
R7 medium. Thereafter, 250,000 T cells/well in 200 
 
m
 
l R7 were added in
triplicate, and the plates were incubated for 3–4 d. For antigen presenta-
tion assays with DCs, developing bone marrow DCs were harvested after
6 d of culture in GM-CSF, placed on ice, and incubated with graded doses
of rabbit anti–DEC-205, anti-MMR, and preimmune serum for 1 h. Un-
bound antibodies were washed away and aliquots of the DCs were seeded
in triplicates into 96-well plates. Then 200,000 T cells/well were added and
cultured for 3–4 d. To assay T cell proliferation, [
 
3
 
H]thymidine (1 
 
m
 
Ci/
well; Amersham Pharmacia Biotech) was added for the last 12 h before
harvesting. Incorporation of radioactivity was determined by scintillation
counting. Data are shown are means of triplicates where the standard de-
viation was 
 
,
 
10% of the mean cpm.
 
Results
 
Unique Localization and Function of DEC-205 in DCs
 
DEC-205 belongs to the group VI family of lectins (Drick-
amer and Taylor, 1993) that contain 8–10 extracellular,
contiguous C-type lectin domains and include the MMR.
Both DEC-205 and MMR can be expressed on DCs (Jiang
et al., 1995; Engering et al., 1997). Rabbit polyclonal anti-
bodies to mouse DEC-205 (Swiggard et al., 1995) and the
mouse MMR (our unpublished data) were used to localize
these receptors in developing mouse DCs, generated from
bone marrow progenitors with GM-CSF (Inaba et al.,
1992). By day 6, the cultures were predominantly imma-
ture DCs with endocytic activity and abundant, intracellu-
lar, late endosomes or lysosomes (Pierre et al., 1997).
These compartments were rich in MHC II products and
are called MIICs.
By confocal laser scan microscopy, both the MMR and
DEC-205 were abundant in intracellular granules (Fig. 1
A, red). As expected for a recycling endocytic receptor,
very little of the MMR was found in late endosomes or ly-
sosomes that were labeled for LAMP-1 or for MHC II
(Fig. 1 A, green and merge images). In marked contrast,
the bulk of the intracellular DEC-205 was localized in
perinuclear MIICs, as demonstrated by colocalization with
LAMP-1 and with MHC II (Fig. 1 A).
To detect a functional consequence for the distinct tar-
geting of the MMR and DEC-205, we used the rabbit poly-
clonal antibodies as surrogate antigens for T cells primed
to rabbit Ig, as Chesnut and Grey (1981) first did to show
presentation via the BCR. When antibodies were added to
immature DCs in the cold, the cells bound comparable
amounts of anti-MMR and DEC-205 Ig (Fig. 1 B, top).
When the same cells were added to cultures of primed T
cells, the anti–DEC-205 was presented with much higher
efficiency (Fig. 1 B, bottom). To rule out that the quantita-
tive difference is due to different allotypic determinants
within the MMR and DEC-205 antibodies, additional ex-
periments were performed using T cells from mice primed
to RbIgG with either anti–DEC-205 or anti-MMR antise-
rum (Fig. 1 C). Here again the anti–DEC-205 was pre-
sented with much higher efficiency regardless of whether
the T cells were derived from animals primed with either
DEC-205 or MMR antibodies. Thus, DEC-205 is normally
found in MIICs, whereas MMR is predominantly found in
early endosomes; when rabbit antibodies are bound to
these two receptors, DEC-205 is much more efficient at
presenting peptides to rabbit Ig–primed, CD4
 
1
 
 T cells.
 
Expression of Chimeric DEC-205/CD16 Receptors in 
Transfected DCEK.ICAM.Hi7 Cells
 
The targeting of endocytic receptors is determined by
amino acid sequences within their intracellular domains
(for review see Bonifacino and Dell’Angelica, 1999). A re-
examination of the cytosolic domains (“tails”) of three ho-
mologous lectins—the MMR, DEC-205, and the phospho-
lipase A2 receptor (PLA2R)—showed the tails of the
MMR and PLA2R to be very similar to each other but dif-
ferent from DEC-205 (gray shading in Fig. 2 A). All three
tails contained a membrane-proximal, putative coated pit
localization sequence (Fig. 2 A, underlined) for uptake
(Collawn et al., 1990), but the distal region of DEC-205
was distinct and included a sequence of three acidic amino
acids (Fig. 2 A, EDE). Interestingly, acidic sequences in
other receptors are implicated in intracellular sorting
(Matter et al., 1993; Voorhees et al., 1995; Wan et al., 1998;
Piguet et al., 1999; Simmen et al., 1999).
To determine which components of the cytoplasmic tail
were required for efficient targeting and presentation via
late endosomes or lysosomes (Fig. 1), we constructed chi-
meric receptors containing the external IgG binding do-
main of the HuFc
 
g
 
III receptor or CD16 and different
DEC-205 cytosolic tails (Fig. 2 B). In addition to the wild-
type (WT) DEC-205 tail, we made truncations to remove
the terminal three amino acids (long tail, LT), residues 19–
31 with the putative EDE distal targeting sequence (inter-
mediate tail, IT), and residues 6–31 with the coated pit se-
quence (short tail, ST). We also made mutants of the 
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DEC-205 tail, converting tyrosine to alanine in the coated
pit sequence (altered tail or AT), and EDE to alanines in
the putative distal targeting sequence. We used the wild-
type MMR tail for comparison.
The CD16 chimeras were transfected into a murine fibro-
blast-like line, DCEK.ICAM.Hi7, which expresses MHC II
as well as the T cell costimulatory molecules B7-1 (CD80)
and ICAM-1 (CD54) (Dubey et al., 1995). Comparable sur-
face expression of each CD16 chimeric receptor was ob-
tained (Fig. 2 C) in the stable transfectants, without altering
expression of MHC II (Fig. 2 C) or B7-1 (not shown).
 
Binding, Uptake, and Recycling of HuIgG by CD16 
Chimeric Receptors
 
To test the function of the chimeric receptors, we first
measured binding of HuIgG as illustrated for WT-DEC:
Figure 1. Distinct intracellular localization and function of DEC-205 and MMR in DCs. (A) Localization. Immature day 6 bone mar-
row DCs (BmDC) (Inaba et al., 1992) were seeded on coverslips, fixed, and double stained with rabbit anti–DEC-205 and MMR (red),
and the late endosomal/lysosomal components, LAMP-1 or MHC II (green). Examples of individual granules that contain red and
green label are marked by arrows, and colocalization is further shown in yellow in the merged images. (B) Surface binding and presen-
tation of anti–DEC-205 and MMR antibodies. Day 6, immature marrow-derived DCs were incubated with different dilutions (as indi-
cated) of anti–DEC-205, anti-MMR, or preimmune rabbit serum on ice for 1 h. Unbound antibody was washed away. The cells were in-
cubated with FITC-labeled anti-Ig, to assess amounts of surface bound antibody by FACS® (top), or cocultured in graded doses with
rabbit IgG–primed T cells, to measure presentation of peptides from rabbit antibodies (bottom). (C) DCs were incubated with 1:100 di-
lution of anti–DEC-205 or anti-MMR rabbit serum on ice for 1 h. Unbound antibody was washed away, and presentation of peptides
from rabbit antibodies was assayed by coculturing the DCs with graded doses of T cells primed with anti–DEC-205 or anti-MMR anti-
serum, respectively. 
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al., 1981). On PAGE, <10% of the HuIgG aggregated
(molecular mass > 200,000 D) upon heating to 65
 
8
 
C for 30
min (Fig. 3 B), so that saturable binding of the expressed
chimeric receptors was occurring at <1 
 
m
 
g/ml of agg-
HuIgG. When the sensitivity of bound ligand to pH was
measured, aggHuIgG began to elute at pH 5, and only
40% remained at pH 4 (Fig. 3 C).
To monitor endocytosis, aggHuIgG was bound to each
transfectant on ice, and aliquots were transferred to 37
 
8
 
C
for 2 h. The FACS
 
®
 
 was used to follow uptake at the single
cell level. Binding of FITC anti-HuIgG to fixed cells de-
tected residual surface HuIgG, and to fixed permeabilized
cells, detected surface and intracellular HuIgG. With WT-
DEC:CD16–expressing cells, HuIgG was no longer detect-
able at the surface after the 2-h chase at 37
 
8
 
C (Fig. 3 D),
but strong staining was obtained in permeabilized cells, in-
dicating that the DEC tail mediated uptake of ligands
bound to a heterologous receptor.
Similar results, i.e., endocytosis of bound HuIgG, were
obtained with cells expressing the LT-, IT-, and AT-DEC:
CD16 chimera (not shown). In contrast, cells transfected
with the short six–amino acid tail (ST-DEC:CD16), lack-
ing the putative coated pit localization sequence, showed
no significant loss of surface IgG (Fig. 3 D), indicating that
deletion of amino acid residues 6–31 prevents endocytosis
of the DEC:CD16 chimeric receptor. In a more detailed
time course study (Fig. 3 E), we included cells expressing
AAA-DEC:CD16 and MMR:CD16. Again, the ST-DEC:
CD16 chimera did not internalize, whereas half the surface
Ig entered the cells via the other CD16 chimeras within 15
min. The AT-DEC:CD16 chimera, which contained a mu-
tation of the tyrosine residue in the coated pit localization
site, was capable of endocytosis although at a somewhat
slower rate (Fig. 3 E). Therefore, all the chimeric CD16 re-
ceptors bound aggHuIgG, and all except the ST-DEC:
CD16 mediated rapid adsorptive uptake of ligand.
To examine recycling of the DEC:CD16 chimeric recep-
tors, we blocked protein synthesis using CHX at 10 
 
m
 
g/ml
for 2 h. We then added a saturating dose of aggHuIgG,
placed the cells on ice, washed, and transferred the L cells
to 37
 
8
 
C. This procedure was sufficient to saturate all of the
CD16 chimeric receptors (data not shown). Thereafter, at
subsequent time points, we added 
 
125
 
I-labeled aggHuIgG to
detect a reappearance of functional CD16 receptors. The
intact cytosolic tails (WT, MMR) recycled within 1 h after
internalization, but the truncated intermediate DEC tail
(IT) and the AAA-DEC:CD16 chimera recycled less rap-
idly (Fig. 3 F). The 1-h recycling time could underestimate
the speed of recycling via the DEC-205 tail, because the pH
of the vacuolar system in L cells may be insufficiently low to
quickly elute all of the bound HuIgG ligand. As expected,
the ST tail did not recycle, i.e., regenerate functional CD16,
because endocytosis was not occurring. To rule out replen-
ishment of receptors from endocytic pools, rather than recy-
cling, we repeated the experiments in cells exposed for 1 h
at 37
 
8
 
C to aggHuIgG to occupy intracellular stores. Again,
recycling of new HuIgG binding receptors took place (data
not shown). We conclude that the DEC-205 and MMR tails
are each capable of mediating ligand uptake, discharge, and
recycling to the cell surface, and that these activities can be
carried out by all of the mutant cytosolic tails we had pre-
pared, except for the short tail lacking the coated pit local-
ization and uptake sequence.
Figure 2. Cytosolic domains used to study the targeting of endocy-
tosis receptors. (A) Sequences of the cytoplasmic domain of three
multilectin receptors for adsorptive endocytosis: DEC-205,
PLA2R, and MMR. Underlining indicates a consensus sequence
for endocytosis via coated pits; boldface indicates a cluster of acidic
residues (EDE), postulated to guide DEC-205 beyond early endo-
somes; gray shading shows similar amino acids in the tails. (B) Mu-
tations were introduced into the DEC tail (arrows), leading to
truncations at the sites denoted (ST, short tail; IT, intermediate tail;
LT, long tail), or to amino acid substitutions: Y to A in alternate
tail (AT), and EDE to AAA in the AAA tail. (C) Surface expres-
sion of CD16 and MHC II in untransfected DCEK.ICAM.Hi7 cells
(none) or cells transfected with CD16 fusion receptors (WT, LT,
IT, ST, AT, AAA, and MMR). Staining was with anti-CD16 (clone
3G8), anti–I-Ek (clone HB32), or isotype control anti–I-Ak (clone
10.216), followed by FITC goat anti–mouse F(ab9)2 antibodies.
 
CD16 (Fig. 3 A). The transfectants all bound ligand. Satu-
ration occurred at 10 
 
m
 
g/ml, whereas the untransfected
DCEK.ICAM.Hi7 cell line (Fig. 3 A, none) did not bind
HuIgG. Binding required that the human IgG be heat ag-
gregated, as expected for functional Fc
 
g
 
RIII (Unkeless et 
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Intracellular Compartments Targeted by CD16 
Chimeric Receptors
 
At this stage of the studies, the DEC-205 and MMR tails
seemed similar. Distinctive features of the DEC-205 tail be-
came apparent upon examining the intracellular targeting
of CD16 chimeric receptors and HuIgG ligand, and in tests
of antigen presentation to HuIgG-primed T cells. First, we
did confocal immunofluorescence microscopy to simulta-
neously identify MHC II and LAMP-1 or the early endoso-
mal marker TfR. In all transfectants (WT shown here),
MHC II largely colocalized with LAMP-1, a marker for late
endosomes/lysosomes in the perinuclear region (Fig. 4,
top), and not with TfR in the periphery (Fig. 4, bottom).
In either the absence or presence of IgG ligand, WT-
DEC:CD16 chimeric receptors efficiently localized to late
endosomal/lysosomal compartments, as shown by colocal-
ization with LAMP-1 and MHC II in the perinuclear re-
gion (left columns of Fig. 5, A and B, respectively). In con-
trast, the MMR:CD16 did not colocalize with LAMP-1
and was found primarily in the peripheral cytoplasm (Fig.
5 A). Receptor targeting to late endosomes was mediated
by sequences found in the distal portion of the cytoplasmic
tail of DEC-205, since DEC-IT:CD16 chimeras, which
lacked amino acids 18–31 in the cytoplasmic tail of DEC-
205, failed to accumulate in MHC II
 
1
 
 lysosomes and were
found in vesicles throughout the cytoplasm (Fig. 5, A and
Figure 3. Ligand binding, uptake, and recycling via CD16 DEC-205 chimeric receptors. (A) Binding of aggHuIgG to transfected cells.
WT-DEC/CD16 transfected cells (WT) and untransfected cells (None) were incubated on ice for 1 h with graded doses of aggHuIgG.
After washing, surface-bound IgG was detected with FITC goat anti-HuIgG F(ab9)2 and FACS®. Cells were also stained for surface
CD16 using 3G8 and FITC goat anti–mouse F(ab9)2. Binding to WT cells and all other transfectants (see Fig. 1) was similar. (B) To de-
tect the small amount of aggHuIgG in the heated HuIgG preparations, samples were analyzed under reducing conditions by SDS-
PAGE analysis. (C) Elution of HuIgG to CD16 at acidic pH. Elution of aggHuIgG to CD16 was performed at different pH’s, predicting
a release of ligand in mildly acidic compartments. (D) Endocytosis of aggHuIgG. Untransfected cells (none) and transfectants with dif-
ferent DEC:CD16 chimeric receptors (WT, ST) were incubated on ice for 1 h with aggHuIgG (10 mg/ml). Aliquots were fixed and
stained for surface-bound HuIgG immediately (bold line) or incubated at 378C for 4 h (thin line) before fixation and staining with
FITC-labeled anti-HuIgG (first column, fixed only). Cells were also permeabilized before staining with FITC-labeled anti-HuIgG (sec-
ond column) to reveal endocytosed HuIgG. (E) Uptake of HuIgG. Cell lines were incubated with aggHuIgG on ice, transferred to 378C
for different times, and stained with FITC-labeled anti-HuIgG F(ab9)2 without or with prior permeabilization. The mean fluorescence
was determined by FACS® analysis, and the amount of internalized IgG was plotted as a percentage of total surface-bound IgG. (F) Re-
cycling of CD16 chimeric receptors. Cells were treated for 2 h with CHX and then incubated with 100 mg/ml aggHuIgG, and transferred
on ice, to saturate binding of all CD16 chimeric receptors (see Fig. 2 A). After washing, the cells were incubated at 378C in the contin-
ued presence of CHX for different times, and recycling CD16 chimeric receptors were detected by binding of 125I-HuIgG. The amount
of recycled receptors is plotted as a percentage of the amount of surface-bound 125I-HuIgG obtained with untreated cells. 
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B). The ST-DEC:CD16 chimera failed to mediate endocy-
tosis completely, and was distributed along the cell mem-
brane (Fig. 5 A).
To follow the targeting of bound ligand, we incubated
the L cells with aggHuIgG for 30 min on ice, followed by a
30-min chase at 37
 
8
 
C. Surface-bound HuIgG was found on
all transfectants after incubation on ice (Fig. 6 A, top),
confirming the FACS
 
®
 
 data (Fig. 3 A). After incubation at
37
 
8
 
C, HuIgG was mainly found in lysosomes in WT-DEC:
CD16 transfectants, colocalizing with LAMP-1 in the peri-
nuclear region (Fig. 6 A, bottom left). In contrast, HuIgG
endocytosed by either IT-DEC:CD16 or MMR:CD16
transfected cells, colocalized with TfR in early endosomes
(data not shown), indicating that ligands bound to these
receptors failed to reach lysosomes efficiently (Fig. 6).
HuIgG bound to the ST-DEC:CD16 chimera remained
surface bound during the 30-min chase period. From these
results, we conclude that the DEC-205 cytoplasmic do-
main targets CD16 chimeras and their ligands to MHC
II
 
1
 
LAMP-1
 
1
 
 vacuoles, whereas the cytoplasmic domain
of the MMR targets primarily to early endosomes. Se-
quences for targeting to late endosomes lie between posi-
tions 18 and 31 in the DEC-205 tail. The different target-
ing routes of MMR:CD16 and AAA-DEC:CD16 versus
WT-DEC:CD16 should be reflected in a different time
course for their recycling of these receptors, but in fact un-
occupied receptors reappeared with a similar pace. How-
ever, the speed of recycling via early endosomal compart-
ments is likely to have been underestimated because the
pH of the early endosomes may be insufficiently low to
quickly elute all of the bound HuIgG ligand.
 
Presentation of Ligands Internalized by Chimeric CD16 
Receptors to CD4
 
1
 
 T Cells
 
To determine whether antigen bound to CD16 chimeric
receptors was processed and presented, we pulsed the
transfected cells with aggHuIgG for 6 h, and assayed for
presentation to primed T lymphocytes. Cells expressing
WT-DEC:CD16 induced strong T cell proliferation, with
saturation concentrations of 1 
 
m
 
g/ml aggHuIgG (Fig. 7 A).
Immune complexes formed with anti-HuIgG and soluble
HuIgG were also presented efficiently, whereas nonaggre-
gated HuIgG, which did not bind to CD16 receptors (Fig.
3 A), only induced occasional T cell proliferation at high
doses (100 
 
m
 
g/ml; Fig. 7, B and C).
When the mutant cytosolic tails were studied, LT-DEC:
CD16 chimeras were indistinguishable from WT-DEC:
CD16 in inducing T cell proliferation at low antigen con-
centrations. AT-DEC:CD16 chimeras (tyrosine 15 sub-
stituted by alanine) showed only a slightly diminished
response. In contrast, IT-DEC:CD16, which mediated en-
docytosis and recycling (Fig. 3, E and F) but failed to tar-
get to MHC II
 
1
 
LAMP-1
 
1
 
 compartments (Fig. 5), was in-
efficient for antigen presentation. Cells expressing MMR:
CD16 chimeras resembled those expressing IT-DEC:
CD16 in that they were only able to stimulate T cell prolif-
eration at high concentrations of HuIgG (10–100 
 
m
 
g/ml;
Fig. 7). ST-DEC:CD16 (lacking the 25 most distal amino
acids in the DEC-205 cytoplasmic domain) did not stimu-
late T cell proliferation above the background obtained
with untransfected DCEK.ICAM.Hi7 cells. These data in-
dicate that sequences required to target antigens for effi-
cient presentation differ from those required for endo-
cytosis and recycling. IT-DEC:CD16 and MMR:CD16
chimeras mediate endocytosis and recycling, but addi-
tional information found between amino acids 18 and 28 in
the DEC-205 cytoplasmic domain is required for targeting
to antigen processing compartments.
 
Importance of the Distal EDE Sequence in the Distinct 
Targeting of the DEC-205 Tail
 
Acidic amino acids are implicated in intracellular targeting,
e.g., the movement of HIV-1 nef protein to lysosomes
(Piguet et al., 1999), the movement of furin to the trans-
Golgi network (Voorhees et al., 1995; Simmen et al., 1999),
and the retrieval of the LDLR from apical to basolateral
membranes of epithelial cells (Matter et al., 1993). To assess
if acidic amino acids in the distal part of the DEC-205 tail
were required for late endosomal targeting, we mutated the
EDE residues to alanines (AAA-DEC:CD16). The AAA-
DEC:CD16 chimera was fully competent for adsorptive up-
take of aggHuIgG and recycling back to the surface (Fig. 3,
Figure 4. Presence of MHC II1 lyso-
somal compartments in CD16
transfectants (WT-DEC:CD16
shown here). Stably transfected
DCEK.ICAM.Hi7 cells on tissue cul-
ture chamber slides were fixed and
double labeled for MHC II and lyso-
somal (LAMP-1) proteins (top) or
TfR (bottom). Primary antibodies
were visualized by FITC- and Texas
red–labeled secondary antibodies. By
confocal laser scan microscopy, MHC
II colocalizes with LAMP-1 in all
cells (yellow) but not with the TfR. 
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Figure 5.
 
Typical distribution of CD16 chimeric receptors in DCEK.ICAM.Hi7 cells in the absence (shown here) or presence of ligand,
10 
 
m
 
g/ml aggHuIgG. (A) CD16 and LAMP-1 double labeling. Cells on tissue culture chamber slides were fixed and stained for CD16
(green, FITC-labeled anti–mouse Ig) and LAMP-1 (red, Texas red–labeled anti–rat Ig). Colocalization in discrete vesicles in WT trans- 
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E and F), but failed to target aggHuIgG or CD16 to lyso-
somes (Fig. 5 B). Consistent with the absence of late endo-
somal targeting, presentation of antigen to IgG-primed T
cells was greatly reduced (Fig. 7 A) and occurred only at
antigen levels comparable to those needed for IT-DEC:
CD16– and MMR:CD16-mediated presentation. Thus, the
EDE in the DEC-205 tail is required for its unique lysoso-
mal targeting and antigen presenting functions.
 
Discussion
 
A Specialized Receptor for Antigen Uptake and 
Presentation on DCs
 
High doses of protein antigens, e.g., 100–1,000 
 
m
 
g/ml, are
typically added to antigen-presenting cells to generate the
MHC II–peptide complexes that are ligands for CD4
 
1
 
 T
cells. The efficiency of antigen binding and uptake is greatly
enhanced by receptor-mediated endocytosis, as occurs with
the MMR (Engering et al., 1997; Prigozy et al., 1997; Tan et
al., 1997), FcR (Sallusto and Lanzavecchia, 1994), and BCR
(Bonnerot and Lankar, 1995). The DEC-205 receptor is ex-
pressed by DCs and is a homologue to the MMR, localizing
to coated pits and enhancing ligand uptake (Jiang et al.,
1995). The MMR primarily recycles through peripheral,
early endosomes (Engering et al., 1997; Tan et al., 1997), al-
though some entry into late endosomes is reported (Prigozy
et al., 1997). In contrast to the MMR, DEC-205 targets to
deep endosomes or lysosomes in DCs rather than early en-
dosomes, the latter being typical for other endocytosis re-
ceptors. The MMR presents mannosylated BSA very effi-
ciently (Sallusto et al., 1995). Surprisingly, when we used
polyclonal rabbit antibodies as surrogate ligands, DEC-205
was much more efficient than the MMR in presenting pep-
tides to rabbit Ig–primed T cells. Since cytosolic domains
guide the movements of adsorptive endocytosis receptors,
we proceeded to study fusion receptors formed by the ex-
ternal domains of human CD16 and different tails, espe-
cially the MMR and DEC-205. In a totally heterologous sys-
tem, i.e., transfected L cells, the DEC-205 tail mediated a
unique recycling pathway through late endosomes rich in
MHC II, and importantly, greatly enhanced antigen presen-
tation relative to the MMR tail. Typically, L cells are ineffi-
cient at producing MHC II–peptide complexes from pro-
teins, and preprocessed peptides are used to study antigen
presentation (Dubey et al., 1995).
Additional work will be needed to pursue the physiolog-
ical implication of these findings, i.e., that DEC-205 is
used by DCs to improve antigen presentation. The follow-
ing types of future experiments would be of value. First, to
assess the role of the distal cytoplasmic tail in the context
of a full length receptor, it would be important to mutate
full length DEC-205; currently, it is not yet feasible to ob-
tain high level expression of this large receptor. Second,
the studies of CD16-DEC fusion receptors could be ex-
tended into DCs using different vectors, and such experi-
ments are underway. Third, ligands for DEC-205 and
MMR need to be identified, so that the presentation of
natural ligands rather than surrogates can be tested. Inter-
estingly, DEC-205 and not the MMR is readily detected
on DCs within the T cell areas of mouse and human lym-
phoid tissues (Linehan et al., 1999; Guo et al., 2000).
 
Two Functional Regions of the DEC-205
Cytosolic Domain
 
The membrane-proximal region of the DEC-205 tail con-
tains the sequence FSSVRY, which resembles the coated
pit localization sequences described in many other recep-
tors (Goldstein et al., 1979). Such sequences function in
 
fected cells is indicated by arrows, and for all the transfectants is displayed in yellow (bottom row). (B) CD16 and MHC II double label-
ing. Cells grown on tissue chamber slides were fixed and stained for CD16 (red) or MHC II (green) with species-specific secondary re-
agents. Slides were analyzed by confocal laser scan microscopy. Examples of colocalization in single vesicles in WT transfected cells are
indicated by arrows and displayed in yellow (bottom row).
 
Figure 5 legend continued
 
 
Figure 6. Intracellular lo-
calization of endocytosed
HuIgG in CD16 transfec-
tants. (A) Double labeling
for endocytosed HuIgG and
LAMP-1. Cells, grown on tis-
sue chamber slides, were in-
cubated with 10 mg/ml
HuIgG for 1 h on ice. Un-
bound HuIgG was washed
away and cells were either
fixed immediately or further
incubated in medium for 30
min at 378C. Cells were dou-
ble stained with FITC-labeled
anti-HuIgG (green) and with
anti–LAMP-1 antibodies (red;
Texas red–labeled second-
ary antibodies).The Journal of Cell Biology, Volume 151, 2000 682
uptake of the LDLR (Chen et al., 1990; Matter et al.,
1993), TfR (Collawn et al., 1990), and MMR (Ezekowitz et
al., 1990). The DEC-205 tail is 31 residues in length. Dele-
tion of residues 19–31 did not reduce endocytosis, but fur-
ther deletion of residues 7–19 including the coated pit se-
quence ablated uptake. Mutation of the tyrosine residue to
alanine did not abolish function, in contrast to decreased
function of other receptors (Chen et al., 1990; Amigorena
et al., 1992b; Jackman et al., 1998), but the uptake rates
were lower relative to wild-type DEC-205 tail. Either the
coated pit sequence of DEC-205 is not totally dependent
on this tyrosine, or another sequence bypasses its need,
e.g., the three acidic residues in the distal tail to be dis-
cussed next (Voorhees et al. 1995; Simmen et al., 1999).
The more intriguing region of the DEC-205 cytosolic
tail was the distal region. Residues 28–31 seemed superflu-
ous, but residues 18–27 were critical for several functions.
In the absence of this “distal targeting sequence,” the
DEC-205 tail did not target either receptor or ligand to
late endosomes and lysosomes (Fig. 5) and did not medi-
ate efficient antigen presentation (Fig. 7). However, the
distal targeting sequence was not required for uptake (Fig.
3 E) and membrane recycling (Fig. 3 F).
A cluster of acidic amino acids (EDE) in the distal
DEC-205 tail proved critical for its distinct intracellular
movements (Figs. 5 and 7). Acidic clusters also mediate
trans-Golgi network retrieval of the mannose-6-phosphate
receptor and furin, the latter interacting with a cytosolic
sorting molecule PACS-1 (Voorhees et al., 1995; Wan et
al., 1998; Simmen et al., 1999). Only two acidic amino acids
in the HIV-1 nef protein signal lysosomal targeting and
degradation of endocytosed CD4 molecules via b-COP
(Piguet et al., 1999). Acidic residues target the LDLR to a
basolateral site during transcytosis (Matter et al., 1992).
The LDLR-related protein contains a cluster of acidic
amino acids as well. This receptor mediates uptake and
degradation of sphingolipids, a2-macroglobulin, and com-
plement component C3 into lysosomes (Hiesberger et al.,
1998; Meilinger et al., 1999), but the involvement of acidic
amino acids in lysosomal targeting has not been described.
The experiments in this paper have compared DEC-205
with MMR, because of similarities in their external multi-
lectin domains and their proposed function in antigen pre-
sentation. Future work will compare the cytosolic domains
of DEC-205 with the LDLR family, as well as function in
non–antigen-presenting cells like epithelial cells.
A Novel Pathway for an Adsorptive
Endocytosis Receptor
As mentioned above (see Introduction), some receptors me-
diate ligand uptake and discharge in early endosomes, fol-
lowed by recycling of intact receptors to the surface and fur-
ther rounds of uptake. Other receptors signal cell activation
and growth, and then uptake is followed by ligand and re-
ceptor digestion in lysosomes. The new pathway, illustrated
by DEC-205, is a hybrid between these two. The cytosolic
domain of this receptor can mediate uptake into deeper vac-
uoles, followed by recycling of ostensibly intact receptor.
Concomitantly, there is a marked improvement in the effi-
ciency with which peptides are salvaged and displayed as
MHC–peptide complexes. It will be important now to follow
the distribution and function of DEC-205 in epithelia and
brain endothelium, where this receptor is also abundant. It
is possible that in epithelia, as in antigen-presenting cells,
DEC-205 will target to deeper proteolytic vacuoles and lead
to the production of biologically active peptides.
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